下载
543年
文章数据和数据
数据
-
图1 治疗失败时间任何理由:LEV + VPA + CLB和其他三联疗法
1风险的患者数量是指患者的数量没有经历事件(即。,the event treatment failure of the event death) at that particular time point (e.g., 3 months) and who are still at risk of experiencing an event (i.e., not censored). CIF = cumulative incidence function; CLB = clobazam; LEV = levetiracetam; n = number of patients; VPA = valproic acid.
图2
时间反复发作:LEV + VPA + CLB和其他三联疗法
1风险的患者数量是指患者的数量没有经历事件(即。,the event treatment failure of the event death) at that particular time point (e.g., 3 months) and who are still at risk of experiencing an event (i.e., not censored).2患者经历了治疗失败(由于副作用,撤军将缓解,或其他原因)在经历反复发作之前不能再体验一线单一疗法LEV或VPA反复发作,因此,治疗失败被处理为竞争风险。CIF =累积发病率函数;CLB = clobazam;列弗= levetiracetam;n =数量的病人;VPA =丙戊酸。
